CLSI GP47 (R2019)

Management of Critical- and Significant-Risk Results, 1st Edition, GP47Ed1E, GP47ESEd1E

Clinical and Laboratory Standards Institute, 12/01/2015

Publisher: CLSI

File Format: PDF

$90.00$180.00


Published:01/12/2015

Pages:112

File Size:2 files , 7.2 MB

Note:This product is unavailable in Russia, Belarus

This guideline provides current best practice recommendations for developing and implementing a policy and procedures for the identification, reporting, and management of critical- and significant-risk laboratory results. Emphasis is placed on management responsibilities such as development of the policy, the process, procedures, job descriptions, and monitoring systems that ensure effective reporting and compliance with regulatory requirements.

Executive Summary
This is an executive summary of GP47–Management of Critical- and Significant-Risk Results. It provides a compilation of all key recommendations from GP47 for policies and processes as well as risk management principles and information technology for the management of laboratory results that indicate critical or significant risk to patients.

More CLSI standard pdf

CLSI M02-Ed13 and M100-Ed29 Package

CLSI M02-Ed13 and M100-Ed29 Package

Performance Standards for Antimicrobial Disk Susceptibility Tests, Thirteenth Edition, M02Ed13E; Performance Standards for Antimicrobial Susceptibility Testing, Twenty-Ninth Edition, M100Ed29E

$171.00 $342.00

CLSI M44-A2

CLSI M44-A2

Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts, 3rd Edition, M44Ed3E

$90.00 $180.00

CLSI M24

CLSI M24

Susceptibility Testing of Mycobacteria, Nocardia spp., and Other Aerobic Actinomycetes, 3rd Edition, M24Ed3E

$90.00 $180.00

CLSI C49 (R2023)

CLSI C49 (R2023)

Analysis of Body Fluids in Clinical Chemistry, 2nd Edition, C49Ed2E

$90.00 $180.00